As a Board Member of the American Vein & Lymphatic Society you must insure balance, independence, objectivity, and ethical rigor in all of the board’s activities. Therefore, the Board of Directors has adopted the concept of implementing a Full Disclosure Policy for Board Members. When performing the board’s work, it is imperative that all members be aware of their colleagues’ external interests and potential conflicts. The formal disclosure provides transparency to our membership and demonstrates that the board is acting with due diligence.
The intent of this disclosure is not to prevent a board member with a significant financial or other relationship from serving on the board, but rather to provide fellow board members and management with full disclosure of potential conflicts of interest.
Board members are required to disclose to the AVLS financial relationships they have with commercial interests of any amount during the past 12 monthly ONLY. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Relationship with governmental agencies and organizations that do not fit the above definition do not have to be disclosed. A list of possible commercial interests includes, but is not limited to:
Also, you must disclose SIGNIFICANT* financial relationships your spouse or life partner has with applicable manufacturers, or provides marketing advice to applicable manufacturers. Disclosure of spousal information should be included in your disclosure in the table on the attached form.
(*“Significant” for spouses or life partners means, for example, holder of a patent, or is employed by a manufacturer you reference.)
The Executive Director of the AVLS will maintain a file which shall include a Full Disclosure Statement obtained from each board member elected to the Board of Directors, and for the Executive Director (see disclosure statements [Sections I & II] on the attached form). Copies of these forms will be published in each board book sent to board members.
You are asked to sign each section separately. Complete and sign those parts which apply to you. All Board Members must read and sign Section II, regardless of their financial or product disclosures.
AVLS Headquarters will send each board member a form on which to update their disclosures twice annually. However, if new conflicts arise between Board meetings, it is your responsibility to update this form and submit revisions to AVLS Headquarters.